Loading…

Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn

AIM To determine if infants who had become dependent on inhaled nitric oxide treatment could be successfully weaned off it if FIO2 was increased briefly during withdrawal. METHODS Sixteen infants admitted for conditions associated with increased pulmonary vascular resistance responded well to inhale...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood. Fetal and neonatal edition 1997-03, Vol.76 (2), p.F118-F122
Main Authors: Aly, Hany, Sahni, Rakesh, Wung, Jen-Tien
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b506t-a97c674de8afe418c23d17670290b8ca9c184d7153e3f7531863020d6402e24b3
cites
container_end_page F122
container_issue 2
container_start_page F118
container_title Archives of disease in childhood. Fetal and neonatal edition
container_volume 76
creator Aly, Hany
Sahni, Rakesh
Wung, Jen-Tien
description AIM To determine if infants who had become dependent on inhaled nitric oxide treatment could be successfully weaned off it if FIO2 was increased briefly during withdrawal. METHODS Sixteen infants admitted for conditions associated with increased pulmonary vascular resistance responded well to inhaled nitric oxide treatment with a significant increase in PaO2 (maximum inhaled nitric oxide given 25 ppm). Weaning from inhaled nitric oxide in 5 ppm decrements was initiated once the FIO2 requirement was less than 0.5. When patients were stable on 5 ppm of inhaled nitric oxide, the gas was then discontinued. If a patient showed inhaled nitric oxide dependence—that is, oxygen saturation fell by more than 10% or below 85%—inhaled nitric oxide was reinstated at 5 ppm and the patient allowed to stabilise for 30 minutes. At this time, FIO2 was increased by 0.40 and weaning from inhaled nitric oxide was attempted again. RESULTS Nine infants were successfully weaned on the first attempt. The seven infants who failed the initial trial were all successfully weaned following the increase in FIO2. After successful weaning, FIO2 was returned to the pre-weaning level in mean 148(SD 51) minutes and inhaled nitric oxide was never reinstated. CONCLUSION Infants showing inhaled nitric oxide dependency can be successfully weaned by increasing FIO2 transiently.
doi_str_mv 10.1136/fn.76.2.F118
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1720630</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78966482</sourcerecordid><originalsourceid>FETCH-LOGICAL-b506t-a97c674de8afe418c23d17670290b8ca9c184d7153e3f7531863020d6402e24b3</originalsourceid><addsrcrecordid>eNp9kc-L1DAcxYso67p68yoEFL3YMUnTJL0IMrijuKwi_jiGNP12mrFNxiTj7vz3pswwqAdPSb7vw-N984riMcELQir-qncLwRd0cUmIvFOcE8ZlSXFN7-Z7VTclbRp5v3gQ4wZjTIQQZ8VZkxXakPNi-A7aWbdGMQWdYL1HNzYNyLpBj9AhZ1OwBvlb2wFKAXSawKUsoy2EaGOaX9vdOHmnwx4N-zzOs2i9Q75HaQDk4Kb1wT0s7vV6jPDoeF4UXy_fflm-K68-rt4v31yVbY15KnUjDBesA6l7YEQaWnVEcIFpg1tpdGOIZJ0gdQVVL-qKSF5hijvOMAXK2uqieH3w3e7aCTqTAwY9qm2wU06ovLbqb8XZQa39L0UExdkrGzw_GgT_cwcxqclGA-OoHfhdVEI2nDNJM_j0H3Djd8Hl5bKXxPmjJZvtXh4oE3yMAfpTFILV3J_qnRJcUTX3l_Enf8Y_wcfCsv7sqOto9NgH7YyNJ4zmJSSbbcoDNld0e5J1-KG4qEStrr8tFV19_rRafmDqOvMvDnw7bf4f8DfrK8A6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780777840</pqid></control><display><type>article</type><title>Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn</title><source>PubMed Central</source><creator>Aly, Hany ; Sahni, Rakesh ; Wung, Jen-Tien</creator><creatorcontrib>Aly, Hany ; Sahni, Rakesh ; Wung, Jen-Tien</creatorcontrib><description>AIM To determine if infants who had become dependent on inhaled nitric oxide treatment could be successfully weaned off it if FIO2 was increased briefly during withdrawal. METHODS Sixteen infants admitted for conditions associated with increased pulmonary vascular resistance responded well to inhaled nitric oxide treatment with a significant increase in PaO2 (maximum inhaled nitric oxide given 25 ppm). Weaning from inhaled nitric oxide in 5 ppm decrements was initiated once the FIO2 requirement was less than 0.5. When patients were stable on 5 ppm of inhaled nitric oxide, the gas was then discontinued. If a patient showed inhaled nitric oxide dependence—that is, oxygen saturation fell by more than 10% or below 85%—inhaled nitric oxide was reinstated at 5 ppm and the patient allowed to stabilise for 30 minutes. At this time, FIO2 was increased by 0.40 and weaning from inhaled nitric oxide was attempted again. RESULTS Nine infants were successfully weaned on the first attempt. The seven infants who failed the initial trial were all successfully weaned following the increase in FIO2. After successful weaning, FIO2 was returned to the pre-weaning level in mean 148(SD 51) minutes and inhaled nitric oxide was never reinstated. CONCLUSION Infants showing inhaled nitric oxide dependency can be successfully weaned by increasing FIO2 transiently.</description><identifier>ISSN: 1359-2998</identifier><identifier>EISSN: 1468-2052</identifier><identifier>DOI: 10.1136/fn.76.2.F118</identifier><identifier>PMID: 9135291</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</publisher><subject>Administration, Inhalation ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; ECMO ; eLetters ; Emergency and intensive care: neonates and children. Prematurity. Sudden death ; Female ; Humans ; Hypertension ; Infant, Newborn ; Infants ; inhaled nitric oxide ; Intensive care medicine ; Male ; Medical sciences ; Nitric oxide ; Nitric Oxide - administration &amp; dosage ; Oxygen - blood ; Persistent Fetal Circulation Syndrome - blood ; Persistent Fetal Circulation Syndrome - therapy ; Ventilator Weaning - methods ; weaning</subject><ispartof>Archives of disease in childhood. Fetal and neonatal edition, 1997-03, Vol.76 (2), p.F118-F122</ispartof><rights>Royal College of Paediatrics and Child Health</rights><rights>1997 INIST-CNRS</rights><rights>Copyright: 1997 Royal College of Paediatrics and Child Health</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b506t-a97c674de8afe418c23d17670290b8ca9c184d7153e3f7531863020d6402e24b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720630/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720630/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2720848$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9135291$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aly, Hany</creatorcontrib><creatorcontrib>Sahni, Rakesh</creatorcontrib><creatorcontrib>Wung, Jen-Tien</creatorcontrib><title>Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn</title><title>Archives of disease in childhood. Fetal and neonatal edition</title><addtitle>Arch Dis Child Fetal Neonatal Ed</addtitle><description>AIM To determine if infants who had become dependent on inhaled nitric oxide treatment could be successfully weaned off it if FIO2 was increased briefly during withdrawal. METHODS Sixteen infants admitted for conditions associated with increased pulmonary vascular resistance responded well to inhaled nitric oxide treatment with a significant increase in PaO2 (maximum inhaled nitric oxide given 25 ppm). Weaning from inhaled nitric oxide in 5 ppm decrements was initiated once the FIO2 requirement was less than 0.5. When patients were stable on 5 ppm of inhaled nitric oxide, the gas was then discontinued. If a patient showed inhaled nitric oxide dependence—that is, oxygen saturation fell by more than 10% or below 85%—inhaled nitric oxide was reinstated at 5 ppm and the patient allowed to stabilise for 30 minutes. At this time, FIO2 was increased by 0.40 and weaning from inhaled nitric oxide was attempted again. RESULTS Nine infants were successfully weaned on the first attempt. The seven infants who failed the initial trial were all successfully weaned following the increase in FIO2. After successful weaning, FIO2 was returned to the pre-weaning level in mean 148(SD 51) minutes and inhaled nitric oxide was never reinstated. CONCLUSION Infants showing inhaled nitric oxide dependency can be successfully weaned by increasing FIO2 transiently.</description><subject>Administration, Inhalation</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>ECMO</subject><subject>eLetters</subject><subject>Emergency and intensive care: neonates and children. Prematurity. Sudden death</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Infant, Newborn</subject><subject>Infants</subject><subject>inhaled nitric oxide</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - administration &amp; dosage</subject><subject>Oxygen - blood</subject><subject>Persistent Fetal Circulation Syndrome - blood</subject><subject>Persistent Fetal Circulation Syndrome - therapy</subject><subject>Ventilator Weaning - methods</subject><subject>weaning</subject><issn>1359-2998</issn><issn>1468-2052</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNp9kc-L1DAcxYso67p68yoEFL3YMUnTJL0IMrijuKwi_jiGNP12mrFNxiTj7vz3pswwqAdPSb7vw-N984riMcELQir-qncLwRd0cUmIvFOcE8ZlSXFN7-Z7VTclbRp5v3gQ4wZjTIQQZ8VZkxXakPNi-A7aWbdGMQWdYL1HNzYNyLpBj9AhZ1OwBvlb2wFKAXSawKUsoy2EaGOaX9vdOHmnwx4N-zzOs2i9Q75HaQDk4Kb1wT0s7vV6jPDoeF4UXy_fflm-K68-rt4v31yVbY15KnUjDBesA6l7YEQaWnVEcIFpg1tpdGOIZJ0gdQVVL-qKSF5hijvOMAXK2uqieH3w3e7aCTqTAwY9qm2wU06ovLbqb8XZQa39L0UExdkrGzw_GgT_cwcxqclGA-OoHfhdVEI2nDNJM_j0H3Djd8Hl5bKXxPmjJZvtXh4oE3yMAfpTFILV3J_qnRJcUTX3l_Enf8Y_wcfCsv7sqOto9NgH7YyNJ4zmJSSbbcoDNld0e5J1-KG4qEStrr8tFV19_rRafmDqOvMvDnw7bf4f8DfrK8A6</recordid><startdate>19970301</startdate><enddate>19970301</enddate><creator>Aly, Hany</creator><creator>Sahni, Rakesh</creator><creator>Wung, Jen-Tien</creator><general>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19970301</creationdate><title>Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn</title><author>Aly, Hany ; Sahni, Rakesh ; Wung, Jen-Tien</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b506t-a97c674de8afe418c23d17670290b8ca9c184d7153e3f7531863020d6402e24b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Administration, Inhalation</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>ECMO</topic><topic>eLetters</topic><topic>Emergency and intensive care: neonates and children. Prematurity. Sudden death</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Infant, Newborn</topic><topic>Infants</topic><topic>inhaled nitric oxide</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - administration &amp; dosage</topic><topic>Oxygen - blood</topic><topic>Persistent Fetal Circulation Syndrome - blood</topic><topic>Persistent Fetal Circulation Syndrome - therapy</topic><topic>Ventilator Weaning - methods</topic><topic>weaning</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aly, Hany</creatorcontrib><creatorcontrib>Sahni, Rakesh</creatorcontrib><creatorcontrib>Wung, Jen-Tien</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of disease in childhood. Fetal and neonatal edition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aly, Hany</au><au>Sahni, Rakesh</au><au>Wung, Jen-Tien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn</atitle><jtitle>Archives of disease in childhood. Fetal and neonatal edition</jtitle><addtitle>Arch Dis Child Fetal Neonatal Ed</addtitle><date>1997-03-01</date><risdate>1997</risdate><volume>76</volume><issue>2</issue><spage>F118</spage><epage>F122</epage><pages>F118-F122</pages><issn>1359-2998</issn><eissn>1468-2052</eissn><abstract>AIM To determine if infants who had become dependent on inhaled nitric oxide treatment could be successfully weaned off it if FIO2 was increased briefly during withdrawal. METHODS Sixteen infants admitted for conditions associated with increased pulmonary vascular resistance responded well to inhaled nitric oxide treatment with a significant increase in PaO2 (maximum inhaled nitric oxide given 25 ppm). Weaning from inhaled nitric oxide in 5 ppm decrements was initiated once the FIO2 requirement was less than 0.5. When patients were stable on 5 ppm of inhaled nitric oxide, the gas was then discontinued. If a patient showed inhaled nitric oxide dependence—that is, oxygen saturation fell by more than 10% or below 85%—inhaled nitric oxide was reinstated at 5 ppm and the patient allowed to stabilise for 30 minutes. At this time, FIO2 was increased by 0.40 and weaning from inhaled nitric oxide was attempted again. RESULTS Nine infants were successfully weaned on the first attempt. The seven infants who failed the initial trial were all successfully weaned following the increase in FIO2. After successful weaning, FIO2 was returned to the pre-weaning level in mean 148(SD 51) minutes and inhaled nitric oxide was never reinstated. CONCLUSION Infants showing inhaled nitric oxide dependency can be successfully weaned by increasing FIO2 transiently.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</pub><pmid>9135291</pmid><doi>10.1136/fn.76.2.F118</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1359-2998
ispartof Archives of disease in childhood. Fetal and neonatal edition, 1997-03, Vol.76 (2), p.F118-F122
issn 1359-2998
1468-2052
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1720630
source PubMed Central
subjects Administration, Inhalation
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
ECMO
eLetters
Emergency and intensive care: neonates and children. Prematurity. Sudden death
Female
Humans
Hypertension
Infant, Newborn
Infants
inhaled nitric oxide
Intensive care medicine
Male
Medical sciences
Nitric oxide
Nitric Oxide - administration & dosage
Oxygen - blood
Persistent Fetal Circulation Syndrome - blood
Persistent Fetal Circulation Syndrome - therapy
Ventilator Weaning - methods
weaning
title Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A29%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Weaning%20strategy%20with%20inhaled%20nitric%20oxide%20treatment%20in%20persistent%20pulmonary%20hypertension%20of%20the%20newborn&rft.jtitle=Archives%20of%20disease%20in%20childhood.%20Fetal%20and%20neonatal%20edition&rft.au=Aly,%20Hany&rft.date=1997-03-01&rft.volume=76&rft.issue=2&rft.spage=F118&rft.epage=F122&rft.pages=F118-F122&rft.issn=1359-2998&rft.eissn=1468-2052&rft_id=info:doi/10.1136/fn.76.2.F118&rft_dat=%3Cproquest_pubme%3E78966482%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b506t-a97c674de8afe418c23d17670290b8ca9c184d7153e3f7531863020d6402e24b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1780777840&rft_id=info:pmid/9135291&rfr_iscdi=true